Santé invests at the leading edge of innovation in healthcare and technology. We manage approximately one billion dollars of capital in two separate strategies.
Santéis a leading early-stage venture capital firm founded in 2006, with offices in Austin and Boston. We invest at the intersection of science and technology, catalyzing disruptive opportunities across Biotech, MedTech and HealthTech. Combining extensive healthcare industry experience with deep scientific and technical expertise, we pursue innovative new opportunities to improve lives and generate returns. At Santé, we fuel entrepreneurs and form next-generation companies which shape the future of patient care, delivering better healthcare outcomes at a lower total cost to the system. Our expertise spans cellular biology, pharmaceutical drug development, device design and engineering, physician and hospital leadership, and public policy.
Our investment philosophy of disciplined fund size, significant ownership positions, and diversified life sciences exposure has proven successful, as our funds have consistently generated top quartile returns for our investors. The firm has nearly $1BN under management and is investing out of Santé Health Ventures IV (a 2021 vintage fund) which follows the same successful investment strategy as our prior funds.